the ST get together in March discussed GXH
Up about 20% since --- hope attendees joined the ride with crackity
Printable View
Bugger - share pricce gone below 120
No worries the share price has increased at a CAGR of 7% pa over the last 10 years - better than the 15% pa decline over the the last 5 years
Hopefully 140 by end of August
The SP drop is caused by the comment "company board bemoan lack of analyst coverage". Who will hold something that does not attract analysts and potential buyers, plus no dividend for a few years.
They really need someone who knows how to do the marketing and branding for them. They do not know what is market, what language cheers up the investors and institutions. Do not blame market and analysts, that is their own fault.
What the hell is going on with gxh share price
Heading below 110 …might even get to 100
Looked so promising in the mid 220s a few weeks ago
Probably my fault. I sold out at 118 some weeks ago ...
Anyway - I still think the company could have an amazing potential as health stock, but probably too many ex MET directors on board.
Bad apple principle might apply. Remember what happend to MET? Shareholders shafted.
Sold out at $1.16 before lockdown. after nearly two year holding, only has 12% gain without dividend, very disappointed and never come back again. It is going back to $1.03-$1.05 price range now.
https://announcements.nzx.com/detail/379015
The only numbers mentioned are.....
"It has taken a 25 per cent shareholding in health technology company PillDrop."
and
"PillDrop launched in 2020 ...."
Hmmmm....time will tell I guess.
Interesting - Greencross in partnership with PEP in talks to acquire Tamaki Health. There are other interested parties also..
https://www.nzx.com/announcements/380023
https://www.tamakihealth.co.nz/about-us/history
Mercury Capital was chosen for its significant expertise to support Nirvana Health Group’s work and vision. The investment is being used to enhance the business of high-quality patient care and grow clinic acquisitions.
This is certainly not one of my better bets, watching nervously. Does management have enough nous to pull this off profitably ? Not sure or confident at all.
Disc: 2% of portfolio….today.